An observational study in Rib Fracture Multiple, sponsored by Shanghai Jiao Tong University Affiliated Sixth People's Hospital. Not yet recruiting. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2023-03-08.
Sponsored by Shanghai Jiao Tong University Affiliated Sixth People's Hospital · Observational
The purpose of this study is to explore the difference between the clinical effects of surgical and non-surgical treatment for patients with low rib fracture, and to explore whether SSRF has more clinical treatment advantages in patients with low rib fracture in a randomized, controlled and prospective manner.
14 studies on the registry are indexed under Fractures, Multiple; 4 are open to participants now.
Browse Fractures, Multiple studies →Shanghai Jiao Tong University Affiliated Sixth People's Hospital is the lead sponsor of 40 studies on the registry; 22 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patient with multiple rib fractures combines with low rib fractures
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
surgical stabilization of low rib fracures by internal fixation
Procedure: surgical stabilization of low rib fratures
conservative treatment of low rib fractures
Other: converstive treatment of low rib fratures
surgical stabiliazation of rib fractures by internal fixation
chest wall fixation band
EQ-5D-5L
appraisal of life quality
Time frame: On the day of admission
EQ-5D-5L
appraisal of life quality
Time frame: 1 week after treatment
EQ-5D-5L
appraisal of life quality
Time frame: 2 weeks after treatment
EQ-5D-5L
appraisal of life quality
Time frame: 1 month after treatment
EQ-5D-5L
appraisal of life quality
Time frame: 3 months after treatment
EQ-5D-5L
appraisal of life quality
Time frame: 6 months after treatment
Pain Score
Number Rating Score, NRS
Time frame: On the day of admission
Pain Score
Number Rating Score, NRS
Time frame: 1 week after treatment
Pain Score
Number Rating Score, NRS
Time frame: 2 weeks after treanment
Pain Score
Number Rating Score, NRS
Time frame: 1 month after treatment
Pain Score
Number Rating Score, NRS
Time frame: 3 months after treatment
Pain Score
Number Rating Score, NRS
Time frame: 6 months after treatment
Atelectasis
CT scan show
Time frame: On the day of admission
Atelectasis
CT scan show
Time frame: 1 week after treatment
Atelectasis
CT scan show
Time frame: 2 weeks after treanment
Atelectasis
CT scan show
Time frame: 1 month after treatment
Atelectasis
CT scan show
Time frame: 3 months after treatment
Atelectasis
CT scan show
Time frame: 6 months after treatment
Pleural effusion
CT scan show
Time frame: On the day of admission
Pleural effusion
CT scan show
Time frame: 1 week after treatment
Pleural effusion
CT scan show
Time frame: 2 weeks after treanment
Pleural effusion
CT scan show
Time frame: 1 months after treatment
Pleural effusion
CT scan show
Time frame: 3 months after treatment
Pleural effusion
CT scan show
Time frame: 6 months after treatment
Mortality
death toll in each group
Time frame: On the day of admission
Mortality
death toll in each group
Time frame: 1 week after treatment
Mortality
death toll in each group
Time frame: 2 weeks after treanment
Mortality
death toll in each group
Time frame: 1 month after treatment
Mortality
death toll in each group
Time frame: 3 months after treatment
Mortality
death toll in each group
Time frame: 6 months after treatment
Length of hospital stay
time of hospitalization
Time frame: the day from in the hospital to discharge
Cost of treatment
total cost of hospitalization expense
Time frame: the day from in the hospital to discharge
Chest discomfort
chest tightness, foreign body sensation, numbness of surgical incision
Time frame: On the day of admission
Chest discomfort
chest tightness, foreign body sensation, numbness of surgical incision
Time frame: 1 week after treatment
Chest discomfort
chest tightness, foreign body sensation, numbness of surgical incision
Time frame: 2 weeks after treanment
Chest discomfort
chest tightness, foreign body sensation, numbness of surgical incision
Time frame: 1 month after treatment
Chest discomfort
chest tightness, foreign body sensation, numbness of surgical incision
Time frame: 3 months after treatment
Chest discomfort
chest tightness, foreign body sensation, numbness of surgical incision
Time frame: 6 months after treatment
Chronic pain
pain for more than three months after surgery or trauma, NRS assessment
Time frame: 3 months after treatment , 6 month after treatment
Chronic pain
pain for more than three months after surgery or trauma, NRS assessment
Time frame: 6 months after treatment
Duration of analgesic drug
the time of analgesic usement from first treat to the paitent do not use it anymore
Time frame: the time of analgesic usement from first treat to the paitent do not use it anymore
Total analgesic drug use
total amont of analgesic usement from first treat to the paitent do not use it anymore
Time frame: the time of analgesic usement from first treat to the paitent do not use it anymore
Lung function 1
Forced vital capacity， FVC
Time frame: On the day of admission
Lung function 1
Forced vital capacity， FVC
Time frame: 1 week after treatment
Lung function 1
Forced vital capacity， FVC
Time frame: 2 weeks after treanment
Lung function 1
Forced vital capacity， FVC
Time frame: 1 month after treatment
Lung function 1
Forced vital capacity， FVC
Time frame: 3 months after treatment
Lung function 1
Forced vital capacity， FVC
Time frame: 6 months after treatment
Lung function 2
First second forced vital capacity，FEV1
Time frame: On the day of admission
Lung function 2
First second forced vital capacity， FEV1
Time frame: 1 week after treatment
Lung function 2
First second forced vital capacity， FEV1
Time frame: 2 weeks after treanment
Lung function 2
First second forced vital capacity， FEV1
Time frame: 1 month after treatment
Lung function 2
First second forced vital capacity， FEV1
Time frame: 3 months after treatment
Lung function 2
First second forced vital capacity， FEV1
Time frame: 6 months after treatment
No study locations are listed for this record.
Start is estimated for Apr 2023; primary completion for Dec 2025, 32 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai Jiao Tong University Affiliated Sixth People's Hospital